New troglitazone derivatives devoid of PPAR agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines

By Colin Christelle   Salamone Stéphane   Grillier-Vuissoz Isabelle   Boisbrun Michel   Kuntz Sandra   Lecomte Julie   Chapleur Yves   Flament Stéphane  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 101-110

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis, Characterization and In Vitro Antiproliferative Effects of Novel 5-Amino Pyrazole Derivatives against Breast Cancer Cell Lines

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 186-195

Bentham Science Publishers

Access to resources Recommend Favorite

Hydroxy Cinnamic Acid Derivatives as Partial PPARγ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562)

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 4, 2017-04 ,pp. : 524-541

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 6, 2014-07 ,pp. : 840-851

Bentham Science Publishers

Access to resources Recommend Favorite

Induction of differentiation and peroxisome proliferator-activated receptor γ expression in colon cancer cell lines by troglitazone

By Kato Masashi   Kusumi Tomomi   Tsuchida Shigeki   Tanaka Masanori   Sasaki Mutsuo   Kudo Hajime  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 2, 2004-02 ,pp. : 73-79

Springer Publishing Company

Access to resources Recommend Favorite